TeraRecon DETECT
Enterprise AI Deployment & Reimbursable Biomarker Management
Commercial (Components awaiting regulatory clearance)Active
Key Facts
Indication
Enterprise AI Deployment & Reimbursable Biomarker Management
Phase
Commercial (Components awaiting regulatory clearance)
Status
Active
Company
About TeraRecon
TeraRecon, founded in 1997 and headquartered in Durham, North Carolina, is a leader in AI-driven advanced visualization for medical imaging. The company's core platform integrates clinical AI algorithms into a unified, subscription-based software suite to streamline diagnostic workflows and support decision-making across hospital systems. As part of ConcertAI's imaging solutions, TeraRecon focuses on enabling the adoption of reimbursable AI biomarkers and consolidating disparate 3D and AI tools into a single, scalable enterprise platform. Its solutions are designed to improve time-to-treatment, increase throughput, and enhance patient outcomes.
View full company profile